These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38531660)

  • 1. Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells.
    Yamauchi N; Otsuka M; Ishikawa T; Kakeji Y; Kikuchi A; Masuda A; Kodama Y; Minami Y; Kamizaki K
    Genes Cells; 2024 Jun; 29(6):503-511. PubMed ID: 38531660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Ror family receptors in Wnt5a signaling.
    Kamizaki K; Minami Y; Nishita M
    In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROR1 and ROR2 expression in pancreatic cancer.
    Liu D; Sharbeen G; Phillips P; ; Ford CE
    BMC Cancer; 2021 Nov; 21(1):1199. PubMed ID: 34763666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
    Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
    EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
    Endo M; Doi R; Nishita M; Minami Y
    J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
    Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
    J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
    Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
    Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC).
    Remtisch L; Wiltberger G; Schierle K; Yousef M; Thieme R; Jansen Winkeln B; Wittekind C; Gockel I; Lyros O
    J BUON; 2021; 26(4):1595-1606. PubMed ID: 34565024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
    Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity.
    Si W; Liu X; Wei R; Zhang Y; Zhao Y; Cui L; Hong T
    Cell Death Dis; 2019 Feb; 10(3):206. PubMed ID: 30814496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival.
    Mittelstädt A; Anthuber A; David P; Podolska M; Bénard A; Brunner M; Krautz C; Jacobsen A; Denz A; Weber K; Merkel S; Hackner D; Buniatov T; Roßdeutsch L; Klösch B; Swierzy I; Hansen FJ; Strobel D; Zopf Y; Baur JO; Van Deun J; Immanuel Geppert C; Gießl A; Lettmaier S; Semrau S; Grützmann R; Kouhestani D; Weber GF
    Front Immunol; 2024; 15():1253072. PubMed ID: 38846943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.
    Zhang S; Chen L; Cui B; Chuang HY; Yu J; Wang-Rodriguez J; Tang L; Chen G; Basak GW; Kipps TJ
    PLoS One; 2012; 7(3):e31127. PubMed ID: 22403610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse regulation of mammary epithelial growth and branching morphogenesis through noncanonical Wnt signaling.
    Kessenbrock K; Smith P; Steenbeek SC; Pervolarakis N; Kumar R; Minami Y; Goga A; Hinck L; Werb Z
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3121-3126. PubMed ID: 28270600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
    Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.